查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
药用明胶市场：2019-2029年全球市场规模、份额、趋势分析、机会和预测报告
市场调查报告书
商品编码
1310390

药用明胶市场：2019-2029年全球市场规模、份额、趋势分析、机会和预测报告

Pharmaceutical Gelatin Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Source ; By Function ; By Type ; By Application ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2029年全球药用明胶市场规模将达到18亿美元

由于对控制的日益关注，例如慢性疾病的增加、明胶的有利特性以及先进的药用明胶的推出，全球药用明胶市场正在蓬勃发展。

领先的战略咨询和市场研究公司 BlueWeave Consulting 最近的一项研究估计，2022 年全球药用明胶市场价值将达到 12.2 亿美元。 BlueWeave预测，在2023-2029年预测期内，全球药用明胶市场规模将以5.48%的年复合成长率增长，2029年达到17.6亿美元。全球药用明胶市场的主要增长促进因素包括对药用明胶的需求不断增长、慢性病新兴市场不断增长、全球人口迅速老龄化以及明胶纳米粒子在药物和疫苗中的利用。明胶在化妆品用途、明胶特定功能、生物医学用途（如伤口敷料和癒合、基因治疗、组织工程、植入物和骨替代品）中的广泛使用进一步推动了市场的扩张。此外，在预测期内，明胶用于药物输送的用途的增加预计也将支持药用明胶市场的扩张。然而，向非明胶胶囊的转变预计将阻碍整个市场的增长。

本报告的详细分析提供了有关全球药用明胶市场的增长潜力、未来趋势和统计数据的信息。我们还关注推动市场总规模预测的因素。该报告致力于提供全球药用明胶市场的最新技术趋势以及行业见解，帮助决策者做出明智的战略决策。它还分析了市场的增长促进因素、挑战和竞争动态。

目录

第1章研究框架

第2章执行摘要

第3章全球药用明胶市场洞察

  • 行业价值链分析
  • DROC分析
    • 增长动力
      • 明胶的优点和特性
      • 推出先进药用明胶
    • 抑制因素
      • 过渡到非明胶胶囊
    • 机会
      • 新兴国家对药用明胶的需求
    • 任务
      • 明胶成本高
  • 技术进步/最新发展
  • 监管框架
  • 波特五力分析

第4章全球药用明胶市场概况

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按来源
      • 猪
      • 牛皮
      • 牛骨
      • 海洋
      • 家禽
    • 按功能分类
      • 稳定剂
      • 增稠剂
      • 稠化剂
      • 其他的
    • 按类型
      • A型
      • B型
    • 按用途
      • 硬胶囊
      • 软胶囊
      • 锭剂
      • 可吸收止血剂
      • 其他的
    • 按地区
      • 北美
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲 (MEA)

第5章北美药用明胶市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按来源
    • 按功能分类
    • 按类型
    • 按用途
    • 按国家/地区
      • 我们
      • 加拿大

第6章欧洲药用明胶市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按来源
    • 按功能分类
    • 按类型
    • 按用途
    • 按国家/地区
      • 德国
      • 英国
      • 意大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他欧洲国家

第7章亚太药用明胶市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按来源
    • 按功能分类
    • 按类型
    • 按用途
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳大利亚和新西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 亚太地区其他国家

第8章拉丁美洲药用明胶市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按来源
    • 按功能分类
    • 按类型
    • 按用途
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 拉丁美洲其他地区

第9章中东和非洲药用明胶市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按来源
    • 按功能分类
    • 按类型
    • 按用途
    • 按国家/地区
      • 沙特阿拉伯
      • 阿拉伯联合酋长国
      • 卡塔尔
      • 科威特
      • 南非
      • 尼日利亚
      • 阿尔及利亚
      • MEA 的其余部分

第10章竞争格局

  • 关键人物及其来源清单
  • 2022年全球药用明胶企业市场份额分析
  • 通过管理参数进行竞争基准测试
  • 主要战略发展（合併、收购、合作伙伴关係等）

第11章COVID-19 对全球药用明胶市场的影响

第12章公司简介（公司简介、财务矩阵、竞争格局、关键人才、主要竞争、联繫地址、战略展望、SWOT分析）

  • Gelita AG
  • Trobas Pharmaceutical gelatine BV
  • Rousselot
  • Weishardt
  • Sterling Gelatin
  • Catalent, Inc
  • Nitta Pharmaceutical gelatin India Limited
  • Aspire Pharmaceuticals
  • Junca Gelatines
  • Gelco International
  • Norland Products Inc
  • Lapi Gelatine Spa
  • Trobus Gelatine BV
  • Other Prominent Players

第13章关键战略建议

第14章调查方法

简介目录
Product Code: BWC23546

Global Pharmaceutical Gelatin Market Size Set to Touch USD 1.8 Billion by 2029.

Global pharmaceutical gelatin market is flourishing because of the growing focus on the management of increasing prevalence of chronic illnesses, favorable properties of gelatin, and the launch of advanced pharma gelatin.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global pharmaceutical gelatin market size at USD 1.22 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global pharmaceutical gelatin market size to grow at a CAGR of 5.48% reaching a value of USD 1.76 billion by 2029. Major growth drivers for the global pharmaceutical gelatin market include an increasing need for pharmaceutical-grade gelatin, the growing prevalence of chronic illnesses, rapidly aging world population, and the progressing developments in the utilization of gelatin nanoparticles in medications and vaccines. The expanding utilization of gelatin in cosmetic applications, its inherent functionalities, as well as its biomedical applications in wound dressing and healing, gene therapy, tissue engineering, implants, and bone substitutes, are further fueling the expansion of the market. Also, the increasing progress in utilizing gelatin for drug delivery purposes is expected to propel the market expansion of pharmaceutical gelatin during the forecast period. However, shift towards non-gelatin capsules is anticipated to hinder the overall market growth.

Global Pharmaceutical Gelatin Market - Overview:

Pharmaceutical gelatin, derived from collagen extracted from animal body parts, is a transparent, long-lasting, inherently tasteless, and odorless food product. It possesses a dry and brittle texture when dry, while being flexible and rubbery when moist. It finds extensive applications as a gelling agent in the pharmaceutical industry for drugs, vitamins, medicines, photographic films & documents, as well as cosmetics. The production process for hard gelatin capsules involves immersing them in a warm bath of gelatin solution, followed by drying, pinning, and cutting of cap and body components, which are then assembled for distribution. These capsules are typically filled with dry forms of pharmaceutical or supplemental products by pharmaceutical or health companies. On the other hand, the manufacturing of soft gelatin capsules begins with the creation of two sheets of soft gelatin, each passing through a die to achieve the desired capsule size and shape. During capsule production, the medication or health supplements are filled with a liquid dose simultaneously. The dose and layer can serve as binding agents to eliminate unpleasant taste and odor, while also facilitating product identification. The specific gelatin melt characteristic also plays a significant role in the controlled and rapid release of medicines. Gelatin is also utilized in the production of suppositories.

Impact of COVID-19 on Global Pharmaceutical Gelatin Market:

COVID-19 pandemic adversely affected the global pharmaceutical gelatin market. Initially, the market experienced disruptions in supply chains and production capacity limitations due to lockdowns, travel restrictions, and disruptions in transportation and logistics. These challenges led to difficulties in procuring raw materials for gelatin production and resulted in limited availability of pharmaceutical gelatin. Also, the pharmaceutical industry as a whole faced delays in clinical trials, regulatory approvals, and new product launches, which indirectly affected the demand for gelatin. However, as the pandemic situation improved and healthcare systems stabilized, the global pharmaceutical gelatin market started showing positive signs of recovery. There was a renewed focus on R&D, including the development of vaccines and therapeutics, which increased the demand for gelatin. Pharmaceutical companies began diversifying their supplier base and exploring alternative sourcing options to enhance supply chain resilience. The market witnessed a gradual rebound in demand for gelatin as healthcare needs resumed, and the industry adapted to the new normal.

Global Pharmaceutical Gelatin Market - By Function:

Based on function, the global pharmaceutical gelatin market is divided into Stabilizing Agent, Thickening Agent, and Gelling Agent segments. The stabilizing agent segment holds the highest share in the global pharmaceutical gelatin market. Stabilizing agents are essential components in the production of gelatin-based pharmaceutical formulations, as they help maintain the stability, integrity, and shelf life of the products. These agents prevent gelatin from undergoing degradation, aggregation, or changes in physical and chemical properties. They play a crucial role in ensuring the quality and efficacy of pharmaceutical gelatin in various applications, including capsules, coatings, and drug delivery systems. The high demand for stabilizing agents is driven by the need for reliable and consistent gelatin formulations that meet regulatory requirements and deliver optimal performance in pharmaceutical applications.

Competitive Landscape:

Major players operating in the global pharmaceutical gelatin market include: Gelita AG, Trobas Pharmaceutical gelatine B.V, Rousselot, Weishardt, Sterling Gelatin, Catalent, Inc, Nitta Pharmaceutical gelatin India Limited, Aspire Pharmaceuticals, Junca Gelatines, Gelco International, Norland Products Inc, Lapi Gelatine S.p.a, and Trobus Gelatine B.V. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Pharmaceutical Gelatin Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Pharmaceutical Gelatin Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Source Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Pharmaceutical Gelatin Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Advantages & properties of Gelatin
      • 3.2.1.2. Launch of Advanced Pharma Gelatin
    • 3.2.2. Restraints
      • 3.2.2.1. Shift Towards Non-Gelatin Capsules
    • 3.2.3. Opportunities
      • 3.2.3.1. Demand of Pharma Gelatin in Developing Countries
    • 3.2.4. Challenges
      • 3.2.4.1. High Cost of Gelatins
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Pharmaceutical Gelatin Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Source
      • 4.2.1.1. Porcine
      • 4.2.1.2. Bovine Skin
      • 4.2.1.3. Bovine Bone
      • 4.2.1.4. Marine
      • 4.2.1.5. Poultry
    • 4.2.2. By Function
      • 4.2.2.1. Stabilizing Agent
      • 4.2.2.2. Thickening Agent
      • 4.2.2.3. Gelling Agent
      • 4.2.2.4. Others
    • 4.2.3. By Type
      • 4.2.3.1. Type A
      • 4.2.3.2. Type B
    • 4.2.4. By Application
      • 4.2.4.1. Hard Capsules
      • 4.2.4.2. Softgel Capsules
      • 4.2.4.3. Tablets
      • 4.2.4.4. Absorbable Hemostats
      • 4.2.4.5. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia Pacific (APAC)
      • 4.2.5.4. Latin America (LATAM)
      • 4.2.5.5. Middle East and Africa (MEA)

5. North America Pharmaceutical Gelatin Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Source
    • 5.2.2. By Function
    • 5.2.3. By Type
    • 5.2.4. By Application
    • 5.2.5. By Country
      • 5.2.5.1. United States
      • 5.2.5.1.1. By Source
      • 5.2.5.1.2. By Function
      • 5.2.5.1.3. By Type
      • 5.2.5.1.4. By Application
      • 5.2.5.2. Canada
      • 5.2.5.2.1. By Source
      • 5.2.5.2.2. By Function
      • 5.2.5.2.3. By Type
      • 5.2.5.2.4. By Application

6. Europe Pharmaceutical Gelatin Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Source
    • 6.2.2. By Function
    • 6.2.3. By Type
    • 6.2.4. By Application
    • 6.2.5. By Country
      • 6.2.5.1. Germany
      • 6.2.5.1.1. By Source
      • 6.2.5.1.2. By Function
      • 6.2.5.1.3. By Type
      • 6.2.5.1.4. By Application
      • 6.2.5.2. United Kingdom
      • 6.2.5.2.1. By Source
      • 6.2.5.2.2. By Function
      • 6.2.5.2.3. By Type
      • 6.2.5.2.4. By Application
      • 6.2.5.3. Italy
      • 6.2.5.3.1. By Source
      • 6.2.5.3.2. By Function
      • 6.2.5.3.3. By Type
      • 6.2.5.3.4. By Application
      • 6.2.5.4. France
      • 6.2.5.4.1. By Source
      • 6.2.5.4.2. By Function
      • 6.2.5.4.3. By Type
      • 6.2.5.4.4. By Application
      • 6.2.5.5. Spain
      • 6.2.5.5.1. By Source
      • 6.2.5.5.2. By Function
      • 6.2.5.5.3. By Type
      • 6.2.5.5.4. By Application
      • 6.2.5.6. Belgium
      • 6.2.5.6.1. By Source
      • 6.2.5.6.2. By Function
      • 6.2.5.6.3. By Type
      • 6.2.5.6.4. By Application
      • 6.2.5.7. Russia
      • 6.2.5.7.1. By Source
      • 6.2.5.7.2. By Function
      • 6.2.5.7.3. By Type
      • 6.2.5.7.4. By Application
      • 6.2.5.8. The Netherlands
      • 6.2.5.8.1. By Source
      • 6.2.5.8.2. By Function
      • 6.2.5.8.3. By Type
      • 6.2.5.8.4. By Application
      • 6.2.5.9. Rest of Europe
      • 6.2.5.9.1. By Source
      • 6.2.5.9.2. By Function
      • 6.2.5.9.3. By Type
      • 6.2.5.9.4. By Application

7. Asia-Pacific Pharmaceutical Gelatin Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Source
    • 7.2.2. By Function
    • 7.2.3. By Type
    • 7.2.4. By Application
    • 7.2.5. By Country
      • 7.2.5.1. China
      • 7.2.5.1.1. By Source
      • 7.2.5.1.2. By Function
      • 7.2.5.1.3. By Type
      • 7.2.5.1.4. By Application
      • 7.2.5.2. India
      • 7.2.5.2.1. By Source
      • 7.2.5.2.2. By Function
      • 7.2.5.2.3. By Type
      • 7.2.5.2.4. By Application
      • 7.2.5.3. Japan
      • 7.2.5.3.1. By Source
      • 7.2.5.3.2. By Function
      • 7.2.5.3.3. By Type
      • 7.2.5.3.4. By Application
      • 7.2.5.4. South Korea
      • 7.2.5.4.1. By Source
      • 7.2.5.4.2. By Function
      • 7.2.5.4.3. By Type
      • 7.2.5.4.4. By Application
      • 7.2.5.5. Australia & New Zealand
      • 7.2.5.5.1. By Source
      • 7.2.5.5.2. By Function
      • 7.2.5.5.3. By Type
      • 7.2.5.5.4. By Application
      • 7.2.5.6. Indonesia
      • 7.2.5.6.1. By Source
      • 7.2.5.6.2. By Function
      • 7.2.5.6.3. By Type
      • 7.2.5.6.4. By Application
      • 7.2.5.7. Malaysia
      • 7.2.5.7.1. By Source
      • 7.2.5.7.2. By Function
      • 7.2.5.7.3. By Type
      • 7.2.5.7.4. By Application
      • 7.2.5.8. Singapore
      • 7.2.5.8.1. By Source
      • 7.2.5.8.2. By Function
      • 7.2.5.8.3. By Type
      • 7.2.5.8.4. By Application
      • 7.2.5.9. Vietnam
      • 7.2.5.9.1. By Source
      • 7.2.5.9.2. By Function
      • 7.2.5.9.3. By Type
      • 7.2.5.9.4. By Application
      • 7.2.5.10. Rest of APAC
      • 7.2.5.10.1. By Source
      • 7.2.5.10.2. By Function
      • 7.2.5.10.3. By Type
      • 7.2.5.10.4. By Application

8. Latin America Pharmaceutical Gelatin Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Source
    • 8.2.2. By Function
    • 8.2.3. By Type
    • 8.2.4. By Application
    • 8.2.5. By Country
      • 8.2.5.1. Brazil
      • 8.2.5.1.1. By Source
      • 8.2.5.1.2. By Function
      • 8.2.5.1.3. By Type
      • 8.2.5.1.4. By Application
      • 8.2.5.2. Mexico
      • 8.2.5.2.1. By Source
      • 8.2.5.2.2. By Function
      • 8.2.5.2.3. By Type
      • 8.2.5.2.4. By Application
      • 8.2.5.3. Argentina
      • 8.2.5.3.1. By Source
      • 8.2.5.3.2. By Function
      • 8.2.5.3.3. By Type
      • 8.2.5.3.4. By Application
      • 8.2.5.4. Peru
      • 8.2.5.4.1. By Source
      • 8.2.5.4.2. By Function
      • 8.2.5.4.3. By Type
      • 8.2.5.4.4. By Application
      • 8.2.5.5. Rest of LATAM
      • 8.2.5.5.1. By Source
      • 8.2.5.5.2. By Function
      • 8.2.5.5.3. By Type
      • 8.2.5.5.4. By Application

9. Middle East & Africa Pharmaceutical Gelatin Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source
    • 9.2.2. By Function
    • 9.2.3. By Type
    • 9.2.4. By Application
    • 9.2.5. By Country
      • 9.2.5.1. Saudi Arabia
      • 9.2.5.1.1. By Source
      • 9.2.5.1.2. By Function
      • 9.2.5.1.3. By Type
      • 9.2.5.1.4. By Application
      • 9.2.5.2. UAE
      • 9.2.5.2.1. By Source
      • 9.2.5.2.2. By Function
      • 9.2.5.2.3. By Type
      • 9.2.5.2.4. By Application
      • 9.2.5.3. Qatar
      • 9.2.5.3.1. By Source
      • 9.2.5.3.2. By Function
      • 9.2.5.3.3. By Type
      • 9.2.5.3.4. By Application
      • 9.2.5.4. Kuwait
      • 9.2.5.4.1. By Source
      • 9.2.5.4.2. By Function
      • 9.2.5.4.3. By Type
      • 9.2.5.4.4. By Application
      • 9.2.5.5. South Africa
      • 9.2.5.5.1. By Source
      • 9.2.5.5.2. By Function
      • 9.2.5.5.3. By Type
      • 9.2.5.5.4. By Application
      • 9.2.5.6. Nigeria
      • 9.2.5.6.1. By Source
      • 9.2.5.6.2. By Function
      • 9.2.5.6.3. By Type
      • 9.2.5.6.4. By Application
      • 9.2.5.7. Algeria
      • 9.2.5.7.1. By Source
      • 9.2.5.7.2. By Function
      • 9.2.5.7.3. By Type
      • 9.2.5.7.4. By Application
      • 9.2.5.8. Rest of MEA
      • 9.2.5.8.1. By Source
      • 9.2.5.8.2. By Function
      • 9.2.5.8.3. By Type
      • 9.2.5.8.4. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Sources
  • 10.2. Global Pharmaceutical Gelatin Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Pharmaceutical Gelatin Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Gelita AG
  • 12.2. Trobas Pharmaceutical gelatine B.V
  • 12.3. Rousselot
  • 12.4. Weishardt
  • 12.5. Sterling Gelatin
  • 12.6. Catalent, Inc
  • 12.7. Nitta Pharmaceutical gelatin India Limited
  • 12.8. Aspire Pharmaceuticals
  • 12.9. Junca Gelatines
  • 12.10. Gelco International
  • 12.11. Norland Products Inc
  • 12.12. Lapi Gelatine S.p.a
  • 12.13. Trobus Gelatine B.V.
  • 12.14. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations